Industry: Medical Devices & Consumables
Published Date: 2025-01-19
Pages: 91 Pages
Report ld: 3429295
Request Sample
Customized Report
Epinephrine Auto-Injectors Market Size(US$)

CAGR 2025-2031
5.1%
Market Size,2031
USD 2,014
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Epinephrine Auto-Injectors was estimated to be worth US$ 1424 million in 2024 and is forecast to a readjusted size of US$ 2014 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure. This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.
Global core Epinephrine Auto-Injectors manufacturers include Viatris, Teva Pharmaceutica etc. The top 1 company hold a share about 42%. North America is the largest market, with a share about 75%, followed by Europe which shares about 20%. In terms of product, 0.3 mg is the largest segment, with a share about 80%. And in terms of application, the largest end user is over 12 years patients.
This report aims to provide a comprehensive presentation of the global market for Epinephrine Auto-Injectors, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Epinephrine Auto-Injectors by region & country, by Type, and by End User.
The Epinephrine Auto-Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epinephrine Auto-Injectors.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Epinephrine Auto-Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Epinephrine Auto-Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Epinephrine Auto-Injectors in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Epinephrine Auto-Injectors Product Introduction
1.2 Global Epinephrine Auto-Injectors Market Size Forecast
1.2.1 Global Epinephrine Auto-Injectors Sales Value (2020-2031)
1.2.2 Global Epinephrine Auto-Injectors Sales Volume (2020-2031)
1.2.3 Global Epinephrine Auto-Injectors Sales Price (2020-2031)
1.3 Epinephrine Auto-Injectors Market Trends & Drivers
1.3.1 Epinephrine Auto-Injectors Industry Trends
1.3.2 Epinephrine Auto-Injectors Market Drivers & Opportunity
1.3.3 Epinephrine Auto-Injectors Market Challenges
1.3.4 Epinephrine Auto-Injectors Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Epinephrine Auto-Injectors Players Revenue Ranking (2024)
2.2 Global Epinephrine Auto-Injectors Revenue by Company (2020-2025)
2.3 Global Epinephrine Auto-Injectors Players Sales Volume Ranking (2024)
2.4 Global Epinephrine Auto-Injectors Sales Volume by Company Players (2020-2025)
2.5 Global Epinephrine Auto-Injectors Average Price by Company (2020-2025)
2.6 Key Manufacturers Epinephrine Auto-Injectors Manufacturing Base and Headquarters
2.7 Key Manufacturers Epinephrine Auto-Injectors Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Epinephrine Auto-Injectors
2.9 Epinephrine Auto-Injectors Market Competitive Analysis
2.9.1 Epinephrine Auto-Injectors Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Epinephrine Auto-Injectors Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epinephrine Auto-Injectors as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0.3 mg
3.1.2 0.15 mg
3.1.3 0.5 mg
3.1.4 0.1 mg
3.2 Global Epinephrine Auto-Injectors Sales Value by Type
3.2.1 Global Epinephrine Auto-Injectors Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Epinephrine Auto-Injectors Sales Value, by Type (2020-2031)
3.2.3 Global Epinephrine Auto-Injectors Sales Value, by Type (%) (2020-2031)
3.3 Global Epinephrine Auto-Injectors Sales Volume by Type
3.3.1 Global Epinephrine Auto-Injectors Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Epinephrine Auto-Injectors Sales Volume, by Type (2020-2031)
3.3.3 Global Epinephrine Auto-Injectors Sales Volume, by Type (%) (2020-2031)
3.4 Global Epinephrine Auto-Injectors Average Price by Type (2020-2031)
4 Segmentation by End User
4.1 Introduction by End User
4.1.1 Under 6 Years Patients
4.1.2 6 to 12 Years Patients
4.1.3 Over 12 Years Patients
4.2 Global Epinephrine Auto-Injectors Sales Value by End User
4.2.1 Global Epinephrine Auto-Injectors Sales Value by End User (2020 VS 2024 VS 2031)
4.2.2 Global Epinephrine Auto-Injectors Sales Value, by End User (2020-2031)
4.2.3 Global Epinephrine Auto-Injectors Sales Value, by End User (%) (2020-2031)
4.3 Global Epinephrine Auto-Injectors Sales Volume by End User
4.3.1 Global Epinephrine Auto-Injectors Sales Volume by End User (2020 VS 2024 VS 2031)
4.3.2 Global Epinephrine Auto-Injectors Sales Volume, by End User (2020-2031)
4.3.3 Global Epinephrine Auto-Injectors Sales Volume, by End User (%) (2020-2031)
4.4 Global Epinephrine Auto-Injectors Average Price by End User (2020-2031)
5 Segmentation by Region
5.1 Global Epinephrine Auto-Injectors Sales Value by Region
5.1.1 Global Epinephrine Auto-Injectors Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Epinephrine Auto-Injectors Sales Value by Region (2020-2025)
5.1.3 Global Epinephrine Auto-Injectors Sales Value by Region (2026-2031)
5.1.4 Global Epinephrine Auto-Injectors Sales Value by Region (%), (2020-2031)
5.2 Global Epinephrine Auto-Injectors Sales Volume by Region
5.2.1 Global Epinephrine Auto-Injectors Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Epinephrine Auto-Injectors Sales Volume by Region (2020-2025)
5.2.3 Global Epinephrine Auto-Injectors Sales Volume by Region (2026-2031)
5.2.4 Global Epinephrine Auto-Injectors Sales Volume by Region (%), (2020-2031)
5.3 Global Epinephrine Auto-Injectors Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Epinephrine Auto-Injectors Sales Value, 2020-2031
5.4.2 North America Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Epinephrine Auto-Injectors Sales Value, 2020-2031
5.5.2 Europe Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Epinephrine Auto-Injectors Sales Value, 2020-2031
5.6.2 Asia Pacific Epinephrine Auto-Injectors Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Epinephrine Auto-Injectors Sales Value, 2020-2031
5.7.2 South America Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Epinephrine Auto-Injectors Sales Value, 2020-2031
5.8.2 Middle East & Africa Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Epinephrine Auto-Injectors Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Epinephrine Auto-Injectors Sales Value
6.2.1 Key Countries/Regions Epinephrine Auto-Injectors Sales Value, 2020-2031
6.2.2 Key Countries/Regions Epinephrine Auto-Injectors Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Epinephrine Auto-Injectors Sales Value, 2020-2031
6.3.2 United States Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Epinephrine Auto-Injectors Sales Value by End User, 2024 VS 2031
6.4 Europe
6.4.1 Europe Epinephrine Auto-Injectors Sales Value, 2020-2031
6.4.2 Europe Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Epinephrine Auto-Injectors Sales Value by End User, 2024 VS 2031
6.5 China
6.5.1 China Epinephrine Auto-Injectors Sales Value, 2020-2031
6.5.2 China Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
6.5.3 China Epinephrine Auto-Injectors Sales Value by End User, 2024 VS 2031
6.6 Japan
6.6.1 Japan Epinephrine Auto-Injectors Sales Value, 2020-2031
6.6.2 Japan Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Epinephrine Auto-Injectors Sales Value by End User, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Epinephrine Auto-Injectors Sales Value, 2020-2031
6.7.2 South Korea Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Epinephrine Auto-Injectors Sales Value by End User, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Epinephrine Auto-Injectors Sales Value, 2020-2031
6.8.2 Southeast Asia Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Epinephrine Auto-Injectors Sales Value by End User, 2024 VS 2031
6.9 India
6.9.1 India Epinephrine Auto-Injectors Sales Value, 2020-2031
6.9.2 India Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
6.9.3 India Epinephrine Auto-Injectors Sales Value by End User, 2024 VS 2031
7 Company Profiles
7.1 Viatris
7.1.1 Viatris Company Information
7.1.2 Viatris Introduction and Business Overview
7.1.3 Viatris Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Viatris Epinephrine Auto-Injectors Product Offerings
7.1.5 Viatris Recent Development
7.2 Teva Pharmaceutica
7.2.1 Teva Pharmaceutica Company Information
7.2.2 Teva Pharmaceutica Introduction and Business Overview
7.2.3 Teva Pharmaceutica Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Teva Pharmaceutica Epinephrine Auto-Injectors Product Offerings
7.2.5 Teva Pharmaceutica Recent Development
7.3 ALK Abello
7.3.1 ALK Abello Company Information
7.3.2 ALK Abello Introduction and Business Overview
7.3.3 ALK Abello Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 ALK Abello Epinephrine Auto-Injectors Product Offerings
7.3.5 ALK Abello Recent Development
7.4 Amneal Pharmaceuticals
7.4.1 Amneal Pharmaceuticals Company Information
7.4.2 Amneal Pharmaceuticals Introduction and Business Overview
7.4.3 Amneal Pharmaceuticals Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Amneal Pharmaceuticals Epinephrine Auto-Injectors Product Offerings
7.4.5 Amneal Pharmaceuticals Recent Development
7.5 Kaléo
7.5.1 Kaléo Company Information
7.5.2 Kaléo Introduction and Business Overview
7.5.3 Kaléo Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Kaléo Epinephrine Auto-Injectors Product Offerings
7.5.5 Kaléo Recent Development
7.6 Bioprojet Pharma
7.6.1 Bioprojet Pharma Company Information
7.6.2 Bioprojet Pharma Introduction and Business Overview
7.6.3 Bioprojet Pharma Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Bioprojet Pharma Epinephrine Auto-Injectors Product Offerings
7.6.5 Bioprojet Pharma Recent Development
7.7 Bausch Health
7.7.1 Bausch Health Company Information
7.7.2 Bausch Health Introduction and Business Overview
7.7.3 Bausch Health Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Bausch Health Epinephrine Auto-Injectors Product Offerings
7.7.5 Bausch Health Recent Development
7.8 Novartis Sandoz
7.8.1 Novartis Sandoz Company Information
7.8.2 Novartis Sandoz Introduction and Business Overview
7.8.3 Novartis Sandoz Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Novartis Sandoz Epinephrine Auto-Injectors Product Offerings
7.8.5 Novartis Sandoz Recent Development
8 Industry Chain Analysis
8.1 Epinephrine Auto-Injectors Industrial Chain
8.2 Epinephrine Auto-Injectors Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Epinephrine Auto-Injectors Sales Model
8.5.2 Sales Channel
8.5.3 Epinephrine Auto-Injectors Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Epinephrine Auto-Injectors market size was US$ 1490 million in 2025 and is forecast to reach a readjusted size of US$ 2108 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 79
USD 4250.00
(Single User License)
The global Epinephrine Auto-Injectors market was valued at US$ 1490 million in 2025 and is anticipated to reach US$ 2108 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 112
USD 2900.00
(Single User License)
The global market for Epinephrine Auto-Injectors was estimated to be worth US$ 1490 million in 2025 and is projected to reach US$ 2108 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 103
USD 3950.00
(Single User License)
The global market for Epinephrine Auto-Injectors was estimated to be worth US$ 1424 million in 2024 and is forecast to a readjusted size of US$ 2014 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-11-03
Pages: 108
USD 3950.00
(Single User License)
The global Epinephrine Auto-Injectors market is projected to grow from US$ 1424 million in 2024 to US$ 2014 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-03
Pages: 135
USD 4900.00
(Single User License)
The global Epinephrine Auto-Injectors market size was US$ 1424 million in 2024 and is forecast to a readjusted size of US$ 2014 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-11-03
Pages: 80
USD 4250.00
(Single User License)
The global market for Epinephrine Auto-Injectors was valued at US$ 1424 million in the year 2024 and is projected to reach a revised size of US$ 2014 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-11-03
Pages: 83
USD 2900.00
(Single User License)
Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure. This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.
Published Date: 2024-01-18
Pages: 95
USD 3950.00
(Single User License)
The global Epinephrine Auto-Injectors market size was US$ 1490 million in 2025 and is forecast to reach a readjusted size of US$ 2108 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 79
The global Epinephrine Auto-Injectors market was valued at US$ 1490 million in 2025 and is anticipated to reach US$ 2108 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-05
Pages: 112
The global market for Epinephrine Auto-Injectors was estimated to be worth US$ 1490 million in 2025 and is projected to reach US$ 2108 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-05
Pages: 103
The global market for Epinephrine Auto-Injectors was estimated to be worth US$ 1424 million in 2024 and is forecast to a readjusted size of US$ 2014 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-11-03
Pages: 108
The global Epinephrine Auto-Injectors market is projected to grow from US$ 1424 million in 2024 to US$ 2014 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-03
Pages: 135
The global Epinephrine Auto-Injectors market size was US$ 1424 million in 2024 and is forecast to a readjusted size of US$ 2014 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-11-03
Pages: 80
The global market for Epinephrine Auto-Injectors was valued at US$ 1424 million in the year 2024 and is projected to reach a revised size of US$ 2014 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-11-03
Pages: 83
Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure. This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.
Published: 2024-01-18
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now